LL-37

LL-37 — Research Use Only LL-37 is a 37-amino-acid peptide released from the C-terminus of hCAP18, the only human cathelicidin, encoded by the CAMP gene. It is studied as a cationic, amphipathic host-defense peptide that adopts an alpha-helical structure in membrane-like environments. Laboratory and preclinical research has examined LL-37 in experimental models involving antimicrobial membrane interaction, lipopolysaccharide binding, innate-immune and inflammatory signaling, formyl-peptide-receptor activity, epithelial-barrier biology, and wound-repair pathways. Most available findings come from cell and animal studies and should not be interpreted as established human safety or therapeutic efficacy. Product Information Product: LL-37 Full name: Human cathelicidin antimicrobial peptide LL-37 Total content: 5 mg Compound type: Host-defense (antimicrobial) peptide Length: 37 amino acids Form: Lyophilized research material Purity: Refer to the product-specific Certificate of Analysis Storage: Store according to the supplied handling documentation Research Applications LL-37 is commonly investigated in connection with: Antimicrobial peptide and membrane-interaction models Lipopolysaccharide-binding assays Innate-immune and inflammatory signaling Formyl-peptide-receptor (FPR2) pharmacology Epithelial-barrier biology Wound-repair and cell-migration pathways Important Notice This product is sold exclusively for laboratory research and analytical purposes. It is not a drug, dietary supplement, food, cosmetic, or medical product. FOR RESEARCH PURPOSES ONLY. NOT FOR HUMAN OR VETERINARY USE. NOT FOR HUMAN CONSUMPTION. This product is not intended to diagnose, treat, cure, mitigate, or prevent any disease. No dosing, administration, infection, wound-care, immune, or therapeutic guidance is provided. Purchasers are responsible for ensuring that possession, handling, and research activities comply with all applicable laws, regulations, and institutional requirements.